" class="no-js "lang="en-US"> Patrick Jeukenne, Aptar Pharma, On Drug Delivery Devices
Thursday, February 06, 2025

Patrick Jeukenne, Aptar Pharma, On Drug Delivery Devices

In the video, Patrick Jeukenne, VP of Strategy Business Development & Marketing at Aptar Pharma, explains the importance of drug delivery devices in ensuring patients receive the correct dose of medication, and how innovation in the field is constantly improving the patient experience. Jeukenne explains the challenges involved in designing drug delivery devices that are user-friendly, easy to use, and safe for patients. He emphasizes the need for collaboration between various stakeholders, including patients, healthcare providers, and device manufacturers, to achieve these goals.

Jeukenne also discusses the potential of connected drug delivery devices, which can collect and transmit data about patients’ medication use to healthcare providers. This technology can improve medication adherence and patient outcomes, but also raises concerns about patient privacy and data security. Jeukenne emphasizes the importance of balancing the benefits of connected devices with these concerns.

Overall, Jeukenne’s discussion highlights the critical role that drug delivery devices play in modern healthcare, and the ongoing efforts to improve their design, functionality, and safety.

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more